Rifampicin – September 2020

• Brand name:
  • Rimycin 150®
  • Rimycin 300®
• Pharmaceutical Company:
  • Mylan
• Condition/Indication: For the treatment of mycobacterium ulcerans infections (Buruli ulcer)
• Meeting Date: September 2020
• Public Summary Document (PSD) July 2020 PBAC Meeting - (PDF KB)
• Public Summary Document (PSD) July 2020 PBAC Meeting - (Word KB)

Related Public Summary Documents

• Rifampicin – July 2020